Psoriasis is an autoimmune disorder that occurs more commonly in
patients with a family history of the disease, and most often begins
in people between the ages of 15 and 35.
Plaque psoriasis, in which patients develop thick, red skin with
flaky, silver-white scales, is the most common form of the disease.
(http://bit.ly/2l9Da9c)
The approval for Siliq injection includes a labeling with boxed
warning to mitigate the risk of suicide. Patients treated with Siliq
during clinical trials had shown suicidal behavior, the FDA noted.
(Reporting by Akankshita Mukhopadhyay in Bengaluru)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
|